CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030

Starting Price : $5000.00 | Pages : 247 | Published : September 2021 | SKU CODE : o&s311 | Format :

Request Sample

CAR-T Therapy Market Definition

The chimeric antigen receptor -T therapy market consists of sales of CAR-T therapy products and related services by entities (organizations, sole traders and partnerships) that develop chimeric antigen receptor (CAR) T-cell therapies to treat blood cancers.

CAR-T therapy is type of immunotherapy in which T-cells taken from patient’s blood are modified in a laboratory with the addition of a special protein receptor that grants T-cells the power to recognize as well as kill cancer cells easily, along with infusing the same back into that patient. This special protein receptor, known as the chimeric antigen receptor (CAR), attaches to a specific protein on a patient’s cancer cells. The infused cells multiply and prevail in the patient’s body as living drugs.

This industry includes establishments that are involved in the research and development to introduce new targeted cell therapies for treating indications related mostly to hematological malignancies. However, some of the pipeline CAR-T therapies are aimed at targeting solid tumors including pancreatic cancer, breast cancer, ovarian cancer, gastric cancer, kidney cancer, brain tumor, and other cancer types.

CAR-T Therapy Market Size

The global CAR-T therapy market reached a value of nearly $1,037 million in 2020.  The market is expected to grow from $1,037.0 million in 2020 to $3,150.0 million in 2025 at a rate of 24.9%. The growth is mainly due to an increased prevalence of cancer and increased awareness about the therapy. The market is expected to stabilize $ 6,100 million in 2030.

Growth in the historic period resulted from increases in healthcare expenditure, increase in pharmaceutical R&D expenditure and advances in drug discovery. This growth was restricted by low rate of drug approvals, challenges due to regulatory changes and limited number of treatment centers.  

Going forward, increase in blood cancer incidence rate, rise in healthcare expenditure, strong pipeline of drugs and rising focus on car-t therapy are expected to drive the market. High costs of therapy, reimbursement challenges, adverse events, complex manufacturing and supply chain and covid-19 impacting drug trails, and reduction in free trade are major factors that could hinder the growth of the CAR-T therapy market in the future.

CAR-T Therapy Market Drivers

The key drivers of the CAR-T therapy market include:  

Increase in Blood Cancer Incidence Rate  

The rise in the number of blood cancer cases across the globe is likely to contribute to the growth of the CAR-T therapy market during the forecast period. According to the American Cancer Society, there were 1,762,450 new cases and 606,880 cancer deaths in 2019 in the USA. New cases of leukemia, lymphoma and myeloma are expected to account for 9.9% of the estimated 1,806,590 new cancer cases diagnosed in the US in 2020 and in approximately every 3 minutes one person in the US is diagnosed with a blood cancer. Therefore, the rise in the blood cancer incidence rate globally is anticipated to boost the demand for the CAR-T therapy market over the forthcoming years.  

CAR-T Therapy Market Restraints

The key restraints on the CAR-T therapy market include:

High Costs Of Therapy  

High costs associated with the CAR-T therapy is a major issue faced by citizens of many countries. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In less wealthy countries, the lack of cost-effective therapies for cancer has influenced the health conditions of the population and has led to a low average life expectancy. According to a 2019 study, factoring in all the costs associated with CAR T-cell therapy, hospitals may charge as much as $1.5 million to avoid losing money, thus restraining the growth of the market.  

CAR-T Therapy Market Trends

Major trends influencing the CAR-T therapy market include:

Remodeled CAR-T Cell Therapy For Fewer Side Effects

The developers and providers of the CAR-T therapy market are investing in research and development to remodel the design of CAR-T therapy to reduce its side effects on cancer patients. The original CAR-T therapy causes neurologic side effects such as delirium, speech problems, seizures and tremors though it provides long-lasting remissions for some patients with very advanced cancer. The remodeled CAR-T therapy with a renewed design results in far fewer neurologic side effects than that of the original therapy. It also helps to reduce the levels of cytokines which cause neurologic side effects. For instance, in February 2020, the National Cancer Institute in the United States modified the design of the original CAR-T therapy and conducted it on 20 patients as trial. The results showed that only one patient out of the 20 in the trial had severe neurologic side effects. The new CAR-T therapy also resulted in the slow growth of tumors and minimized the levels of cytokines.  

Collaborating With Technology Companies for Advanced Technologies:  

Companies in the CAR-T therapy market are increasingly partnering or collaborating with technologies companies to integrate advanced technologies for the betterment of CAR-T therapy. Advanced technologies such as artificial intelligence (AI) and big data are used for personalizing and manufacturing improved CAR-T therapies. For instance, in October 2019, Novartis, a multinational pharmaceutical company headquartered in Switzerland, entered into a five-year partnership with Microsoft, a technology company headquartered in the United States, to develop and deploy the applications of its artificial intelligence capabilities on improving and personalizing the manufacturing of their CAR-T cancer therapies. The partnership also provides Microsoft the ability to test its AI technology for precise uses including CAR-T therapy manufacturing.

Opportunities And Recommendations In The CAR-T Therapy Market

Opportunities –The top opportunities in the CAR-T therapy market segmented by target antigen will arise in the CD19 segment, which will gain $790.0 million of global annual sales by 2025. The top opportunities in the CAR-T therapy market segmented by application will arise in the diffuse large B-cell lymphoma segment, which will gain $850.0 million of global annual sales by 2023. The CAR-T therapy market size will gain the most in the USA at $803.4 million.

Recommendations-To take advantage of these opportunities, The Business Research Company recommends the CAR-T therapy companies to focus on adoption of machine learning and artificial intelligence technologies, remodeled CAR-T cell therapy, expanding in countries offering advanced technologies, focus on developed markets, offer bundled payments, increase visibility through websites, focus on patient referral systems, focus on hospitals and other treatment centers among other strategies.

CAR-T Therapy Market Segmentation

The CAR-T therapy market is segmented by target antigen, by application, by geography.
By Target Antigen –
The CAR-T therapy market is segmented by target antigen into
    • a) CD19
    • b) CD22
    • c) BCMA
    • d) Others
The CD19 was the largest segment of the CAR-T therapy market by target antigen, accounting for 100% of the total market in 2020. Going forward, CD19 segment is expected to be the fastest growing segment in the CAR-T therapy market, at a CAGR of 12.0%.
By Application –
The CAR-T therapy market is segmented by application into
    • a) Acute Lymphoblastic Leukemia
    • b) Diffuse Large B-Cell Lymphoma
    • c) Follicular Lymphoma
    • d) Chronic Lymphocytic Leukemia
    • e) Multiple Myeloma
    • f) Others
The diffuse large B-cell lymphoma was the largest segment of the CAR-T therapy market by application, accounting for 54.0% of the total market in 2020. Going forward, the others segment is expected to be the fastest growing segment in the CAR-T therapy market, at a CAGR of 71.1%.
By Geography-
The CAR-T therapy market is segmented by geography into
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the global CAR-T therapy market, accounting for 56.1% of the total in 2020. It was followed by Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the CAR-T therapy market will be Asia Pacific and Western Europe, where growth will be at CAGRs of 53.8% and 23.3% respectively.

CAR-T Therapy Competitive Landscape

Major Competitors In The CAR-T Therapy Market Are:

  • Gilead Sciences
  • Novartis AG
  • Other Competitors In The CAR-T Therapy Market Include:

  • Biocon (India)
  • Gracell Biotechnology Ltd
  • Aeon Therapeutics
  • CARsgen Therapeutics
  • Daiichi Sankyo
  • Celegne
  • Otsuka Pharmaceutical
  • Ono Pharmaceutical
  • Japan Tissue Engineering
  • Nipro Corporation
  • Takeda Pharmaceutical Company
  • Astellas Pharma.
  • Innovative Cellular Therapeutics
  • Cellular Biomedicine Group
  • PersonGen Biomedicine
  • Hebei Senlang Biotech
  • Adaptimmune (UK)
  • Autolus Therapeutics
  • BioNTech
  • Cellectis
  • Celyad
  • Crescendo Biologics
  • GammaDelta Therapeutics
  • Biocad
  • Celgene Corporation
  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd
  • Eli Lilly and Company
  • Pfizer
  • Amgen
  • AstraZeneca
  • Bayer AG
  • Sandoz AG (A Novartis Division)
  • GlaxoSmithKline plc
  • Elekta (Saudi Arabia)
  • SudairPharma (Saudi Arabia)
  • AstraZeneca (Kuwait)
  • Janssen (Kuwait)
  • Novartis (Kuwait)
  • Roche (Kuwait)
  • Eurolab
  • Sanofi
  • Aspen
    1. Table Of Contents

      1.   CAR-T Therapy Market Executive Summary

      2.  Table of Contents

      3.   List of Figures

      4.  List of Tables

      5.  Report Structure

      6.  Introduction

      6.1. Segmentation By Geography

      6.2. Segmentation By Target Antigen

      6.3. Segmentation By Application

      7.   CAR-T Therapy Market Characteristics

      7.1. Market Definition

      7.2. Market Segmentation By Target Antigen

      7.2.1. CD19 Therapy

      7.2.2. CD22 Therapy

      7.2.3. BCMA Therapy

      7.2.4. Others

      7.3. Market Segmentation By Application

      7.3.1. Acute Lymphoblastic Leukemia

      7.3.2. Diffuse Large B-Cell Lymphoma

      7.3.3. Follicular Lymphoma

      7.3.4. Chronic Lymphocytic Leukemia

      7.3.5. Multiple Myeloma

      7.3.6. Others

      8.  CAR-T Therapy Market, COVID Impact Analysis

      8.1. Impact On Global CAR-T Therapy

      8.2. Impact On Global CAR-T Therapy Clinical Trials

      8.3. Impact On People Undergoing CAR-T Therapy

      8.4. Impact On Leading Global Oncology Companies

      8.5. Future Outlook

      9.  CAR-T Therapy Market Trends And Strategies

      9.1. Remodeled CAR-T Cell Therapy For Fewer Side Effects

      9.2. Off-The-Shelf Allogeneic CAR-T Therapy For Improved Treatment

      9.3. Next-Generation CAR-T Cells For Treatment Of High-Grade Glioma

      9.4. Machine Learning And Artificial Intelligence To Optimize Future CAR-T Therapy

      9.5. Collaborating With Technology Companies For Advanced Technologies

      9.6. Growing Partnerships For Promoting CAR-T Therapy Market

      10. Global CAR-T Therapy Market Size And Growth

      10.1. Market Size

      10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

      10.2.1. Drivers Of The Market 2015 – 2020

      10.2.2. Restraints On The Market 2015 – 2020

      10.3. Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      10.3.1. Drivers Of The Market 2020 – 2025

      10.3.2. Restraints On The Market 2020 – 2025

      11. Global CAR-T Therapy Market Segmentation

      11.1. Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.1.1. CD19

      11.1.2. CD22

      11.1.3. BCMA

      11.2. Global CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.2.1. Diffuse Large B-Cell Lymphoma

      11.2.2. Acute Lymphoblastic Leukemia

      11.2.3. Follicular Lymphoma

      11.2.4. Multiple Myeloma

      12. CAR-T Therapy Market, Regional And Country Analysis

      12.1. Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      12.2. Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13. Asia-Pacific CAR-T Therapy Market

      13.1. Asia-Pacific CAR-T Therapy Market Overview

      13.1.1. Region Information

      13.1.2. Market Information

      13.1.3. Impact of COVID-19

      13.1.4. Background Information

      13.1.5. Government Initiatives

      13.1.6. Regulations

      13.1.7. Regulatory Bodies

      13.1.8. Major Associations

      13.1.9. Taxes Levied

      13.1.10. Corporate Tax Structure

      13.1.11. Investment

      13.1.12. Major Companies

      13.2. Asia-Pacific CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.3. Asia-Pacific CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.4. Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.5. Asia-Pacific CAR-T Therapy Market: Country Analysis

      13.6. China CAR-T Therapy Market

      13.7. China CAR-T Therapy Market Overview

      13.7.1. Country Information

      13.7.2. Market Information

      13.7.3. Impact of COVID-19

      13.7.4. Background Information

      13.7.5. Government Initiatives

      13.7.6. Regulations

      13.7.7. Regulatory Bodies

      13.7.8. Major Associations

      13.7.9. Taxes Levied

      13.7.10. Corporate Tax Structure

      13.7.11. Investment

      13.7.12. Major Companies

      13.8. China CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.9. China CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.10. China CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.11. India CAR-T Therapy Market

      13.12. India CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.13. India CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.14. Japan CAR-T Therapy Market

      13.15. Japan CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.16. Japan CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.17. Japan CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.18. Australia CAR-T Therapy Market

      13.19. Australia CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.20. Australia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.21. Indonesia CAR-T Therapy Market

      13.22. Indonesia CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.23. Indonesia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.24. South Korea CAR-T Therapy Market

      13.25. South Korea CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.26. South Korea CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      13.27. South Korea CAR-T Therapy Market, Segmentation By Application , Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14. Western Europe CAR-T Therapy Market

      14.1. Western Europe CAR-T Therapy Market Overview

      14.1.1. Region Information

      14.1.2. Market Information

      14.1.3. Impact of COVID-19

      14.1.4. Background Information

      14.1.5. Government Initiatives

      14.1.6. Regulations

      14.1.7. Regulatory Bodies

      14.1.8. Major Associations

      14.1.9. Taxes Levied

      14.1.10. Corporate Tax Structure

      14.1.11. Investments

      14.1.12. Major Companies

      14.2. Western Europe CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.3. Western Europe CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      14.4. Western Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.5. Western Europe CAR-T Therapy Market: Country Analysis

      14.6. UK CAR-T Therapy Market

      14.7. UK CAR-T Therapy Market Overview

      14.7.1. Country Information

      14.7.2. Market Information

      14.7.3. Impact of COVID-19

      14.7.4. Background Information

      14.7.5. Government Initiatives

      14.7.6. Regulations

      14.7.7. Regulatory Bodies

      14.7.8. Associations

      14.7.9. Taxes Levied

      14.7.10. Corporate Tax Structure

      14.7.11. Investments

      14.7.12. Major Companies

      14.8. UK CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.9. UK CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      14.10. UK CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.11. Germany CAR-T Therapy Market

      14.12. Germany CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.13. Germany CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      14.14. Germany CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.15. France CAR-T Therapy Market

      14.16. France CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.17. France CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      14.18. France CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15. Eastern Europe CAR-T Therapy Market

      15.1. Eastern Europe CAR-T Therapy Market Overview

      15.1.1. Region Information

      15.1.2. Market Information

      15.1.3. Impact of COVID-19

      15.1.4. Background Information

      15.1.5. Government Initiatives

      15.1.6. Regulations

      15.1.7. Regulatory Bodies

      15.1.8. Associations

      15.1.9. Taxes Levied

      15.1.10. Corporate Tax Structure

      15.1.11. Investments

      15.1.12. Major Companies

      15.2. Eastern Europe CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      15.3. Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.4. Eastern Europe CAR-T Therapy Market: Country Analysis

      15.5. Russia CAR-T Therapy Market

      15.6. Russia CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      15.7. Russia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16. North America CAR-T Therapy Market

      16.1. North America CAR-T Therapy Market Overview

      16.1.1. Region Information

      16.1.2. Market Information

      16.1.3. Impact Of COVID-19

      16.1.4. Background Information

      16.1.5. Government Initiatives

      16.1.6. Regulations

      16.1.7. Regulatory Bodies

      16.1.8. Major Associations

      16.1.9. Taxes Levied

      16.1.10. Corporate Tax Structure

      16.1.11. Investments

      16.1.12. Major Companies

      16.2. North America CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.3. North America CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      16.4. North America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.5. North America CAR-T Therapy Market: Country Analysis

      16.6. USA CAR-T Therapy Market

      16.7. USA CAR-T Therapy Market Overview

      16.7.1. Country Information

      16.7.2. Impact Of COVID-19

      16.7.3. Market Information

      16.7.4. Background Information

      16.7.5. Government Initiatives

      16.7.6. Regulations

      16.7.7. Regulatory Bodies

      16.7.8. Major Associations

      16.7.9. Corporate Tax Structure

      16.7.10. Investments

      16.7.11. Major Companies

      16.8. USA CAR-T Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.9. USA CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      16.10. USA CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17. South America CAR-T Therapy Market

      17.1. South America CAR-T Therapy Market Overview

      17.1.1. Region Information

      17.1.2. Market Information

      17.1.3. COVID Impact

      17.1.4. Background Information

      17.1.5. Government Initiatives

      17.1.6. Regulations

      17.1.7. Regulatory Bodies

      17.1.8. Major Associations

      17.1.9. Taxes Levied

      17.1.10. Corporate Tax Structure

      17.1.11. Investments

      17.1.12. Major Companies

      17.2. South America CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      17.3. South America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.4. South America CAR-T Therapy Market: Country Analysis

      17.5. Brazil CAR-T Therapy Market

      17.6. Brazil CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      17.7. Brazil CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18. Middle East CAR-T Therapy Market

      18.1.Middle East CAR-T Therapy Market Overview

      18.1.1. Region Information

      18.1.2. Market Information

      18.1.3. Impact of COVID-19

      18.1.4. Background Information

      18.1.5. Government Initiatives

      18.1.6. Regulations

      18.1.7. Regulatory Bodies

      18.1.8. Major Associations

      18.1.9. Investments

      18.1.10. Taxes Levied

      18.1.11. Corporate Tax Structure

      18.1.12. Major Companies

      18.2. Middle East CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      18.3.Middle East CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19. Africa CAR-T Therapy Market

      19.1.Africa CAR-T Therapy Market Overview

      19.1.1. Region Information

      19.1.2. Market Information

      19.1.3. Impact Of COVID-19

      19.1.4. Background Information

      19.1.5. Government Initiatives

      19.1.6. Regulations

      19.1.7. Regulatory Bodies

      19.1.8. Major Associations

      19.1.9. Investments

      19.1.10. Taxes Levied

      19.1.11. Corporate Tax Structure

      19.1.12. Major Companies

      19.2. Africa CAR-T Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

      19.3.Africa CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      20. Global CAR-T Therapy Market Competitive Landscape

      20.1. Company Profiles

      20.2. Gilead Sciences

      20.2.1. Company Overview

      20.2.2. Products And Services

      20.2.3. Business Strategy

      20.2.4. Financial Overview

      20.3. Novartis AG

      20.3.1. Company Overview

      20.3.2. Products And Services

      20.3.3. Business Strategy

      20.3.4. Financial Overview

      21. CAR-T Therapy Pipeline Analysis

      21.1.Comparison Of The Landscape Of Active Trials Of Cancer Cell Therapies In 2020

      21.2. CAR T-Cell Therapy, Number Of Active Trials By Cancer Type

      21.3.CAR T-Cell Therapy, Number Of Active Trials By Cancer Type

      21.4. Global CAR-T Cell Therapy By Trial Site

      21.5. Number of Molecules In Cancer Clinical Trails, By Target

      21.6. CAR-T Cell Therapy Pipeline Analysis

      22. Key Mergers And Acquisitions In The CAR-T Therapy Market

      22.1. ResTORbio Merged With Adicet Bio

      22.2. Astellas Pharma Acquired Xyphos Biosciences

      22.3. Bristol Myers Squibb Acquired Celgene Corporation

      22.4. Celgene Acquired Juno Therapeutics

      22.5. Gilead Sciences Acquired Cell Design Labs

      22.6. Gilead Sciences Acquired Kite Pharma

      23. CAR-T Therapy Market Opportunities & Strategies

      23.1.Global CAR-T Therapy Market In 2025 – Countries Offering Most New Opportunities

      23.2. Global CAR-T Therapy Market In 2025 – Segments Offering Most New Opportunities

      23.3.Global CAR-T Therapy Market In 2025 – Growth Strategies

      23.3.1. Market Trend Based Strategies

      23.3.2. Competitor Strategies

      24. CAR-T Therapy Market, Conclusions And Recommendations

      24.1. Conclusions

      24.2. Recommendations

      24.2.1. Product

      24.2.2. Place

      24.2.3. Price

      24.2.4. Promotion

      24.2.5. People

      25. Appendix

      25.1. Market Data Sources

      25.2. Research Methodology

      25.3. Currencies

      25.4. Research Inquiries

      25.5. The Business Research Company

      25.6. Copyright and Disclaimer

    List Of Tables

      Table 1: Global CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 2: Global CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 3: Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 4: Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 5: Global CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 6: Global CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 7: Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 8: Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 9: Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 10: Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 11: Asia-Pacific CAR-T Therapy Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 12: Asia-Pacific CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 13: Asia-Pacific Blood Cancer Drugs Market Size, 2015-2019, $ Billion
    • Table 14:  Asia Pacific Five-Year Prevalence Of Blood Related Cancers, 2015-2019
    • Table 15: Asia-Pacific CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 16: Asia-Pacific CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 17: Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 18: Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 19: China Per Capita Healthcare Expenditure, 2015-2019, $
    • Table 20: China CAR-T Therapy Market, Population By Age Group, 2015-2025, Thousands
    • Table 21: China Blood Cancer Drugs Market Size, 2015-2019, $ Billion
    • Table 22:  China Five-Year Prevalence Of Blood Related Cancers, 2015-2019
    • Table 23: China CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 24: China CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 25: China CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 26: China CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Millio
    • Table 27: India CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 28: India CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 29: India CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 30: Japan CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 31: Japan CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 32: Japan CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 33: Japan CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 34: Australia CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 35: Australia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 36: Australia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 37: Indonesia CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 38: Indonesia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 39: Indonesia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 40: South Korea CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 41: South Korea CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 42: South Korea CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 43: South Korea CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 44: Western Europe Per Capita Healthcare Expenditure, 2015-2019, $
    • Table 45: Western Europe CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 46: Western Europe Blood Cancer Drugs Market Size, 2015-2019, $ Billion
    • Table 47:  Western Europe Five-Year Prevalence Of Blood Related Cancers, 2015-2019
    • Table 48: Corporate Tax Structure In Western Europe Countries, %
    • Table 49: Western Europe CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 50: Western Europe CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 51: Western Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 52: Western Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 53: UK Per Capita Healthcare Expenditure, 2015-2019, $
    • Table 54: UK CAR-T Therapy Market, Population By Age Group, 2015-2025, Thousands
    • Table 55: UK Blood Cancer Drugs Market Size, 2015-2019, $ Billion
    • Table 56:  UK Five-Year Prevalence Of Blood Related Cancers, 2015-2019
    • Table 57: UK CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 58: UK CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 59: UK CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 60: UK CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 61: Germany CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 62: Germany CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 63: Germany CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 64: Germany CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 65: France CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 66: France CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 67: France CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 68: France CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 69: Eastern Europe Per Capita Healthcare Expenditure, 2015-2019, $
    • Table 70: Eastern Europe CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 71: Eastern Europe Blood Cancer Drugs Market Size, 2015-2019, $ Billion
    • Table 72:  Eastern Europe Five-Year Prevalence Of Blood Related Cancers, 2015-2019
    • Table 73: Eastern Europe CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 74: Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 75: Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 76: Russia CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 77: Russia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 78: Russia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 79: North America Per Capita Healthcare Expenditure, 2015-2019, $
    • Table 80: North America CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 81: North America Blood Cancer Drugs Market Size, 2015-2019, $ Billion
    • Table 82:  North America Five-Year Prevalence Of Blood Related Cancers, 2015-2019
    • Table 83: North America CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 84: North America CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 85: North America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 86: North America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 87: USA Per Capita Healthcare Expenditure, 2015-2019, $
    • Table 88: USA CAR-T Therapy Market, Population By Age Group, 2015-2025, Thousands
    • Table 89: USA Blood Cancer Drugs Market Size, 2015-2019, $ Billion
    • Table 90:  USA Five-Year Prevalence Of Blood Related Cancers, 2015-2019
    • Table 91: USA CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 92: USA CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 93: USA CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 94: USA CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 95: South America Per Capita Healthcare Expenditure, 2015-2019, $
    • Table 96: South America CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 97: South America Blood Cancer Drugs Market Size, 2015-2019, $ Billion
    • Table 98:  South America Five-Year Prevalence Of Blood Related Cancers, 2015-2019
    • Table 99: South America CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 100: South America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 101: South America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 102: Brazil CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 103: Brazil CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 104: Brazil CAR-T Therapy Market, Segmentation By Application , Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 105: Middle East Per Capita Healthcare Expenditure, 2015-2019, $
    • Table 106: Middle East CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 107: Middle East Blood Cancer Drugs Market Size, 2015-2019, $ Billion
    • Table 108:  Middle East Five-Year Prevalence Of Blood Related Cancers, 2015-2019
    • Table 109: Middle East CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 110: Middle East CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 111: Middle East CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 112: Africa Per Capita Healthcare Expenditure, 2015-2019, $
    • Table 113: Africa CAR-T Therapy Market, Population By Age Group, By Country, 2015-2025, Thousands
    • Table 114: Africa Blood Cancer Drugs Market Size, 2015-2019, $ Billion
    • Table 115:  Africa Five-Year Prevalence Of Blood Related Cancers, 2015-2019
    • Table 116: Africa CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 117: Africa CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 118: Africa CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 119: Global CAR-T Therapy Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Table 120: Gilead Sciences – Financial Performance, 2016– 2020, $ Billion
    • Table 121: Novartis AG – Financial Performance, 2016 – 2020, $ Billion
    • Table 122:  Pipeline Analysis Of CAR-T Cell Therapy
    • Table 123: Global CAR-T Therapy Market Size Gain ($ Million), 2020 – 2025, By Country
    • Table 124: Global CAR-T Therapy Market Size Gain ($ Million), Segmentation By Target Antigen, 2020 – 2025
    • Table 125: Global CAR-T Therapy Market Size Gain ($ Million), Segmentation By Application, 2020 – 2025
    • Table 126: CAR-T Therapy Market - Data Sources

    List Of Figures

      Figure 1: Global CAR-T Therapy Market Segmentation By Target Antigen
    • Figure 2: Global CAR-T Therapy Market Segmentation By Application
    • Figure 3: Global CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 4: Global CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 5: Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 6: Global CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 7: Global CAR-T Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 8: Global CAR-T Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 9: Asia-Pacific CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 10: Asia-Pacific CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 11: Asia-Pacific CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 12: China CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 13: China CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 14: China CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 15: India CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 16: India CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 17: Japan CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 18: Japan CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 19: Japan CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 20: Australia CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 21: Australia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 22: Indonesia CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 23: Indonesia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 24: South Korea CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 25: South Korea CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 26: South Korea CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 27: Western Europe CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 28: Western Europe CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 29: Western Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 30: UK CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 31: UK CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 32: UK CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 33: Germany CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 34: Germany CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 35: Germany CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 36: France CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 37: France CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 38: France CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 39: Eastern Europe CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 40: Eastern Europe CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 41: Russia CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 42: Russia CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 43: North America CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 44: North America CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 45: North America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 46: USA CAR-T Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 47: USA CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 48: USA CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 49: South America CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 50: South America CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 51: Brazil CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 52: Brazil CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 53: Middle East CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 54: Middle East CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 55: Africa CAR-T Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 56: Africa CAR-T Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 57: Global CAR-T Therapy Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Figure 58: Gilead Sciences – Financial Performance, 2016 – 2020, $ Billion
    • Figure 59: Novartis AG – Financial Performance, 2016– 2020, $ Billion
    • Figure 60: CAR-T Therapy Market, Comparison Of The Landscape Of Active Trials Of Cancer Cell Therapies In 2020
    • Figure 61: CAR-T Therapy Market, Number Of Active Trials By Cancer Type
    • Figure 62: CAR-T Therapy Market, Number Of Active Trials By Cancer Type
    • Figure 63: CAR-T Therapy Market, Global CAR-T Cell Therapy By Trial Site
    • Figure 64: CAR-T Therapy Market, Number of Molecules In Cancer Clinical Trials, By Target
    Global Anti-Infective Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Cell and Gene Therapy Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Pharmaceutical Drugs And Biologics Logistics Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Pharmaceutical Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Microbiome Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global G-CSF (Granulocyte Colony Stimulating Factors) Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Therapeutic Proteins Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Cancer Monoclonal Antibodies Global Market Report 2021 - By Monoclonal Antibody Therapies (Bevacizumab (Avastin), Rituximab (Rituxan), Trastuzumab (Herceptin), Cetuximab (Erbitux), Panitumumab (Vectibix)), By Application (Breast Cancer, Blood Cancer, Liver Cancer, Brain Cancer, Colorectal Cancer), By End User (Hospitals And Clinics, Research Laboratories, Pharmacies), COVID-19 Growth And Change
    View Report
    Pharmaceutical Drugs Global Market Report 2021 - By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorders Drugs, Musculoskeletal Disorders Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Diseases Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), COVID-19 Impact And Recovery
    View Report
    Cancer Biologics Global Market Report 2021 - By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy), By Application (Hospitals, Clinics), COVID-19 Growth And Change
    View Report
    Pharmaceutical Excipients Global Market Report 2021 - By Functionality (Fillers And Diluents, Suspending And Viscosity Agents, Coating Agents, Binders, Flavouring Agents And Sweetners, Disintegrants, Colorants, Lubricants And Glidants), By Type Of Formulation (Oral Fromulation, Topical Formulation, Parental Formulation), By Product (Inorganic Chemicals, Organic Chemicals), COVID-19 Growth And Change
    View Report
    Pharmaceutical Sterility Testing Global Market Report 2021 - By Sample (Sterile Drugs, Medical Devices, Biologics And Therapeutics), By Product Type (Instruments, Kits And Reagents, Services), By Type (In-house, Outsourcing), By Test Type (Sterility Testing, Bioburden Testing, Bacterial Endotoxin Testing), By End-User (Compounding Pharmacies, Medical Devices Companies, Pharmaceutical Companies), COVID-19 Growth And Change
    View Report
    Pharmaceutical API Manufacturing Global Market Report 2021 - By Therapy Area (Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncology, Musculoskeletal Disorders, NSAIDs, Other Therapeutics Uses), By API Type (Chemical API, Biological API), By Drug Type (Innovative Drugs, Generic Prescription, Over-The-Counter (OTC) Drugs), COVID-19 Growth And Change
    View Report
    Pharma Microbiology Testing Kits Global Market Report 2021 - By Product (Consumables, Equipment), By Test (Endotoxin Testing, Sterility Testing, Microbial Examination, Environmental Monitoring), By End User (Hospitals & Diagnostic Centers, Custom Lab Service Providers, Academic & Research Institutes), COVID-19 Growth And Change
    View Report
    Pharmaceutical Drugs And Biologics Logistics Market - By Type Of Service (Cold Chain Logistics, Non-Cold Chain Logistics), By Mode Of Transport (Air Transportation, Ocean Transportation, Land Transportation), By Pharmaceutical Type (Pharmaceutical Drugs, Biologics), By Therapeutic Area (Metabolic Disorders Drugs, Anti-Infective Drugs, Central Nervous System Drugs, Respiratory Diseases Drugs, Cardiovascular Drugs, Musculoskeletal Disorders Drugs, Oncology Drugs, Hematology Drugs, Monoclonal Antibodies (MAbS), Genito-Urinary Drugs, Gastrointestinal Drugs, Therapeutic Proteins, Dermatology Drugs, Vaccines, Ophthalmology Drugs), And By Region, Opportunities And Strategies - Global Forecast To 2030
    View Report

    Call Us

    +1 3156230293

    (Americas)

    +44 2071930708

    (Europe)

    +91 8897263534

    (Asia & Others)